Local News

WakeMed names new chief quality and medical staff officer

Posted December 5, 2019 6:22 p.m. EST

— WakeMed Health & Hospitals said Thursday it has named a new senior vice president and chief quality officer for the system.

Dr. Chris DeRienzo, who is board-certified in general pediatrics and neonatal-perinatal medicine, officially joined WakeMed on Dec. 2, according to a statement issued Thursday.

Before WakeMed, Dr. DeRienzo served as chief medical officer at Cardinal Analytx Solutions in Palo Alto, Calif., an artificial-intelligence-enabled health insights company.

He was also an adjunct professor of population health at Stanford University.

Dr. DeRienzo will lead the analysis, design, development and implementation of systems, processes and outcomes related to clinical quality, patient safety and accreditation in both our ambulatory and inpatient settings.

He will collaborate with leaders and staff, including the medical staff to help implement best practices to achieve outstanding patient care.

“Quality and safety are always priorities in health care and WakeMed will no doubt benefit from Dr. DeRienzo’s experience and leadership in the coming years. We are proud to have him as part of the WakeMed family,” commented Donald Gintzig, WakeMed president & CEO.

He held leadership positions at Mission Health in Asheville, serving as chief quality officer and was responsible for quality, safety, patient experience, service excellence, analytics, continuous improvement and sustainability across the system’s six hospitals and over 120 ambulatory sites.

He received his bachelor’s degree in biology/biochemistry/psychology from Brandeis University in Massachusetts, earned a master’s degree in public policy, and his medical degree from Duke University.

He completed his fellowship in neonatal-perinatal medicine at Duke University Hospital, followed by a research fellowship at the Duke Patient Safety Center.

Our commenting policy has changed. If you would like to comment, please share on social media using the icons below and comment there.